Sustained Viral Response (SVR) / Rapid Virologic Response (RVR) / Early Viral Response (EVR) / End of Treatment Response (EOT)
Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes - 6/24/08 Sustained Virological Response to Pegylated Interferon Alfa-2b (PegIntron) with or without Ribavirin Predicts Continued Response through 5 Years - 5/30/08 Very Early Response to Interferon-based Therapy for Hepatitis C Is Apparent within the First 24 Hours - 5/30/08Duration of Pegylated Interferon plus Ribavirin May Be Tailored Based on Early Response - 1/04/08 Induction with High-dose Pegylated Interferon alfa-2a (Pegasys) Is More Effective than Standard Dosing for Achieving Rapid and Early Virological Response: The CHARIOT Study - 11/20/07 Virological Response and Safety Outcomes in Chronic Hepatitis C Patients Treated with Pegylated Interferon plus Taribavirin (Viramidine) - 8/10/07 72-week Treatment with Pegylated Interferon plus Ribavirin Can Produce Sustained Virological Response in Some Prior Relapsers - 6/15/07 Does Attainment of Sustained Virologic Response (SVR) from Treatment of HCV Constitute a Cure? - 6/01/07
A Follow-up Week 12 Viral Count Is Useful in Predicting SVR and Is 100% Accurate in Patients without Cirrhosis - 6/01/07
Statins Improve Sustained Response to Interferon-based Therapy in Small Study - 5/25/07
Does Attainment of Sustained Virologic Response (SVR) from Treatment of HCV Constitute a Cure? - 5/20/07
FDA-approved Combination Therapies for Chronic HCV Infection
Pegasys + Copegus PEG-Intron + Rebetol Intron A + Rebetol Roferon A + Ribavirin Treatment Guidelines
HCV Articles by Topic
HCV Liver Issues Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis